Fish oil treatment tested for kids with liver damage from IV nutrition
NCT ID NCT06274788
First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study is testing the safety of Omegaven, a fish oil-based fat emulsion, in 40 children under 18 who have developed liver problems (cholestasis) from long-term IV nutrition. The main goal is to see how many children develop essential fatty acid deficiency during at least 8 weeks of treatment. Researchers will also watch for symptoms like dry skin, hair loss, and poor growth.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Omegaven (fish oil triglycerides) injectable emulsion
What this could lead to
If successful, this could show that Omegaven is a safe way to provide essential fats and calories to children with liver problems caused by IV nutrition.
What could go wrong
This is a small, early-phase safety study with only 40 participants. It may not prove effectiveness, and some children might still develop fatty acid deficiency or other side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MALNUTRITION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Baylor College of Medicine Houston
RECRUITINGHouston, Texas, 77030, United States
-
Board of Regents of the University of Oklahoma Health Sciences Center
RECRUITINGOklahoma City, Oklahoma, 73104, United States
-
Children's Hospital Corporation d/b/a Boston Children's Hospital
RECRUITINGBoston, Massachusetts, 02115, United States
-
Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
Memorial Health Service
RECRUITINGFountain Valley, California, 92708, United States
-
Seattle Children's Hospital d/b/a Seattle Children's Research Institute
RECRUITINGSeattle, Washington, 98105, United States
-
The University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
-
The University of Texas Health Science Center at San Antonio
RECRUITINGSan Antonio, Texas, 78229-3901, United States
-
University of California Los Angeles
RECRUITINGLos Angeles, California, 10911, United States
-
Vanderbilt University Medical Center
RECRUITINGNashville, Tennessee, 37232, United States